Colgate-Palmolive
About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
Employees: 34,000
0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 9 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
24% more first-time investments, than exits
New positions opened: 204 | Existing positions closed: 164
14% more call options, than puts
Call options by funds: $415M | Put options by funds: $365M
2.13% more ownership
Funds ownership: 80.55% [Q3] → 82.69% (+2.13%) [Q4]
0% more funds holding
Funds holding: 1,881 [Q3] → 1,884 (+3) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 10 [Q3] → 10 (+0) [Q4]
10% less repeat investments, than reductions
Existing positions increased: 630 | Existing positions reduced: 697
9% less capital invested
Capital invested by funds: $68.5B [Q3] → $62.1B (-$6.38B) [Q4]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$86
10%
downside
Avg. target
$98
3%
upside
High target
$109
14%
upside
9 analyst ratings
5 positive
56%
3 neutral
33%
1 negative
11%
UBS Peter Grom 50% 1-year accuracy 13 / 26 met price target | 14%upside $109 | Buy Maintained | 17 Apr 2025 |
Barclays Lauren Lieberman 52% 1-year accuracy 48 / 92 met price target | 10%downside $86 | Equal-Weight Maintained | 11 Apr 2025 |
JP Morgan Andrea Teixeira 44% 1-year accuracy 28 / 64 met price target | 1%downside $95 | Overweight Maintained | 11 Apr 2025 |
Wells Fargo Chris Carey 53% 1-year accuracy 27 / 51 met price target | 8%downside $88 | Underweight Maintained | 2 Apr 2025 |
Piper Sandler Korinne Wolfmeyer 27% 1-year accuracy 12 / 45 met price target | 12%upside $107 | Overweight Maintained | 31 Mar 2025 |
Financial journalist opinion
Based on 23 articles about CL published over the past 30 days
Neutral
Zacks Investment Research
3 hours ago
Colgate-Palmolive (CL) Reports Next Week: What Awaits?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive
Seeking Alpha
1 day ago
My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys
March investments totaled around $1,200, mainly in BDCs like Blue Owl Capital and Ares Capital, boosting annual dividend income by $100. Dividend income hit a new all-time record of $1,404, up 17% Y/Y driven by substantial purchases over the last twelve months. Focus remains firmly on maintaining rising BDC dividends and achieving a monthly increase of at least $100 in dividend income.
Positive
Zacks Investment Research
3 days ago
ADRNY vs. CL: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Colgate-Palmolive (CL). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Business Wire
1 week ago
Colgate-Palmolive Webcasts 2025 First Quarter Earnings Conference Call April 25, 2025 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 first quarter earnings conference call on Friday, April 25, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.
Positive
Zacks Investment Research
1 week ago
Colgate's Pricing & Productivity Efforts Progress Well: Apt to Hold?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Positive
Market Watch
1 week ago
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have led to seesaw intraday action.
Positive
Seeking Alpha
1 week ago
Bloomberg April Watch List Shows 6 Ideal "Safer" Dividend Buys
Bloomberg Intelligence analysts identified 50 watchable firms for 2025, focusing on catalysts like leadership changes, acquisitions, and new products, with emphasis on AI and electric vehicles. Sixteen of the 35 dividend-paying companies are deemed "safer" with free cash flow yields exceeding dividend yields, including HSBC, China Hongqiao, and ITV. Analysts forecast net gains between 30.99% to 70.82% for top dividend focus companies by April 2026, with Broadcom and Subsea 7 leading projections.
Neutral
Seeking Alpha
2 weeks ago
Trump Tariffs Drama: Staples Companies To The Rescue?
President Trump's “Liberation Day” announcement rattled the market, leaving only few stocks in the green. The likelihood of a stagflationary environment and recession has increased significantly. Even though the intent of the tariffs seems clear, we can expect significant pain in the short term (and possibly longer term). In this article, I take a look at four sub-segments of the consumer staples sector and explore whether relevant stocks should be considered as portfolio hedges in the current environment.
Positive
Investopedia
2 weeks ago
Coca-Cola, General Mills Lift Staples Stocks as Trump Tariffs Weigh on Markets
Stock-market investors are playing defense today.
Positive
Seeking Alpha
2 weeks ago
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Charts implemented using Lightweight Charts™